Should You Buy RIBOLIFE-B (06938) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast 06938 stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast 06938 stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 49.000
Low
0
Averages
0
High
0
0
Current: 49.000
Low
0
Averages
0
High
0
China Merchants Securities (HK)
China Merchants Securities (HK)
Overweight
initiated
$105
AI Analysis
2026-06-22
New
Reason
China Merchants Securities (HK)
China Merchants Securities (HK)
Price Target
$105
AI Analysis
2026-06-22
New
initiated
Overweight
Reason
China Merchants Securities (HK) initiated coverage on RIBOLIFE-B with an Overweight rating and a target price of 105 due to optimism about its core asset RBD4059, a novel siRNA anticoagulant targeting coagulation factor XI, which is anticipated to be a new-generation long-acting anticoagulation therapy. The global anticoagulant market is projected to grow significantly, and RIBOLIFE-B is expected to generate substantial revenue in the coming years despite anticipated annual losses.
